Lumbard & Kellner’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.32M Hold
2,520
0.8% 38
2025
Q4
$2.71M Hold
2,520
0.95% 39
2025
Q3
$1.92M Hold
2,520
0.71% 44
2025
Q2
$1.96M Hold
2,520
0.86% 40
2025
Q1
$2.08M Sell
2,520
-573
-19% -$477K 0.92% 42
2024
Q4
$2.39M Hold
3,093
1.03% 42
2024
Q3
$2.74M Sell
3,093
-187
-6% -$168K 1.21% 39
2024
Q2
$2.97M Sell
3,280
-555
-14% -$444K 1.4% 34
2024
Q1
$2.98M Sell
3,835
-1,530
-29% -$1.09M 1.45% 30
2023
Q4
$3.13M Sell
5,365
-154
-3% -$89.9K 1.81% 23
2023
Q3
$2.96M Hold
5,519
1.97% 21
2023
Q2
$2.51M Hold
5,519
1.4% 29
2023
Q1
$2.19M Hold
5,519
1.1% 35
2022
Q4
$2.02M Hold
5,519
0.99% 35
2022
Q3
$1.78M Hold
5,519
0.92% 38
2022
Q2
$1.79M Hold
5,519
0.91% 42
2022
Q1
$1.58M Hold
5,519
0.62% 45
2021
Q4
$1.35M Hold
5,519
0.51% 47
2021
Q3
$1.27M Hold
5,519
0.5% 51
2021
Q2
$1.27M Hold
5,519
0.49% 50
2021
Q1
$1.01M Hold
5,519
0.35% 53
2020
Q4
$1.15M Sell
5,519
-370
-6% -$55.2K 0.45% 53
2020
Q3
$768K Sell
5,889
-66
-1% -$10.2K 0.38% 47
2020
Q2
$978K Hold
5,955
0.56% 38
2020
Q1
$826K Hold
5,955
0.55% 40
2019
Q4
$783K Hold
5,955
0.4% 45
2019
Q3
$666K Hold
5,955
0.36% 48
2019
Q2
$660K Hold
5,955
0.35% 46
2019
Q1
$773K Hold
5,955
0.43% 41
2018
Q4
$689K Hold
5,955
0.42% 41
2018
Q3
$639K Hold
5,955
0.33% 45
2018
Q2
$508K Hold
5,955
0.3% 44
2018
Q1
$461K Hold
5,955
0.26% 47
2017
Q4
$503K Hold
5,955
0.26% 50
2017
Q3
$509K Hold
5,955
0.28% 54
2017
Q2
$490K Hold
5,955
0.28% 54
2017
Q1
$501K Hold
5,955
0.3% 54
2016
Q4
$438K Hold
5,955
0.28% 48
2016
Q3
$478K Hold
5,955
0.33% 49
2016
Q2
$469K Hold
5,955
0.35% 50
2016
Q1
$429K Hold
5,955
0.31% 49
2015
Q4
$502K Buy
5,955
+2,255
+61% +$187K 0.37% 47
2015
Q3
$310K Sell
3,700
-300
-8% -$25.3K 0.25% 53
2015
Q2
$334K Hold
4,000
0.24% 55
2015
Q1
$291K Hold
4,000
0.21% 63
2014
Q4
$276K Hold
4,000
0.2% 66
2014
Q3
$259K Hold
4,000
0.18% 71
2014
Q2
$249K Hold
4,000
0.18% 68
2014
Q1
$204K Hold
4,000
0.17% 64
2013
Q4
$204K Buy
+4,000
New +$200K 0.17% 64

Other funds holding LLY

Lumbard & Kellner's LLY Position: Q1 2026 in Review

Lumbard & Kellner held its Eli Lilly (LLY) position steady in Q1 2026 at 2,520 shares worth $2.32M. The position accounts for 0.8% of the portfolio, ranked #38.

Lumbard & Kellner first reported a position in LLY in Q4 2013 and has held it in 50 quarters since. The position peaked at $3.13M in Q4 2023. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Lumbard & Kellner held 2,520 shares of Eli Lilly worth $2.32M as of Q1 2026.
  • Lumbard & Kellner left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.8% of Lumbard & Kellner's portfolio in Q1 2026, its #38 holding.
  • Lumbard & Kellner first reported a position in Eli Lilly in Q4 2013 and has held it in 50 quarters since.
  • Lumbard & Kellner's Eli Lilly position peaked at $3.13M in Q4 2023.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Lumbard & Kellner's 13F filing for Q1 2026, filed 15 May 2026.